Article
High Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates with Lower Survival
2021-10-08
Abstract excerpt
Glioblastoma (GBM), the most aggressive brain tumor, is associated with a median survival at diagnosis of 16-20 months and limited treatment options. The key hallmark of GBM is altered tumor metabolism and marked increase in the rate of glycolysis. Aerobic glycolysis along with elevated glucose consumption and lactate production supports rapid cell proliferation and GBM growth. In this study, we examined the gene...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d6a97b33-6e40-54aa-baf4-87e038fc11d8
- DOI
- 10.1101/2021.10.07.463555
